Patient Groups Urge Congress To Support Biosimilars

Law360, New York (September 24, 2009, 6:14 PM EDT) -- A coalition of 27 patient advocacy groups is urging U.S. lawmakers working on massive health care reform to include bipartisan amendments creating a regulatory pathway for generic versions of biologic drugs.

In a letter to congressional leaders last week, Washington-based Colon Cancer Alliance and several other organizations said they supported amendments passed in U.S. House of Representatives and Senate committees to add a biosimilars provision to their health care proposals.

“In the face of the larger unresolved questions relating to the broader health care reform package,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.